Sugi Predict

Sugi Predict / Compounds / SCHEMBL6565462

SCHEMBL6565462

SCHEMBL6565462

OCCCCC1=CCCC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.38
▸ LMNA P02545 1/20 0.37
▸ ALOX15 P16050 3/20 0.37
▸ PKM P14618 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TAAR1 Q96RJ0 1/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ USP2 O75604 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13368669 0.98 ALDH1A1 (0.38) ALDH1A1LMNAALOX15PKMCYP1A2
SCHEMBL10378541 0.94 ALDH1A1 (0.43) ALDH1A1LMNAALOX15PKMCYP1A2
SCHEMBL9933665 0.93 — —
SCHEMBL7931579 0.92 ALDH1A1 (0.43) ALDH1A1LMNAALOX15PKMCYP1A2
SCHEMBL7919931 0.92 ALDH1A1 (0.43) ALDH1A1LMNAALOX15PKMCYP1A2
SCHEMBL17373980 0.92 ALDH1A1 (0.43) ALDH1A1LMNAALOX15PKMCYP1A2
SCHEMBL7931580 0.92 ALDH1A1 (0.43) ALDH1A1LMNAALOX15PKMCYP1A2
SCHEMBL9176557 0.89 ALDH1A1 (0.42) ALDH1A1ALOX15PKMTAAR1SMN1; SMN2
SCHEMBL955334 0.87 ALDH1A1 (0.44) ALDH1A1ALOX15PKMTAAR1SMN1; SMN2
SCHEMBL9755511 0.86 ALDH1A1 (0.41) ALDH1A1ALOX15PKMTAAR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12616948-B2 Polyamide microcapsules FIRMENICH SA (CH) 2026-05-05 — — US disclosed
US-12544730-B2 Process for preparing microcapsules FIRMENICH SA (CH) 2026-02-10 — — US disclosed
US-12480075-B2 Perfume delivery system FIRMENICH SA (CH) 2025-11-25 — — US disclosed
US-20250345252-A1 COMPOSITE MICROCAPSULES FIRMENICH & CIE (CH) 2025-11-13 — — US disclosed
US-12383477-B2 Composite microcapsules FIRMENICH SA (CH) 2025-08-12 — — US disclosed
US-20240375074-A9 POLYAMIDE MICROCAPSULES FIRMENICH & CIE (CH) 2024-11-14 — — US disclosed
US-12138610-B2 Process for preparing mineralized microcapsules FIRMENICH SA (CH) 2024-11-12 — — US disclosed
US-20240042410-A1 PROCESS FOR PREPARING MICROCAPSULES FIRMENICH SA (CH) 2024-02-08 — — US disclosed
US-11666881-B2 Process for preparing polysuccinimide derivatives-based microcapsules FIRMENICH SA (CH) 2023-06-06 — — US disclosed
US-20230036889-A1 Perfume Delivery System FIRMENICH SA (CH) 2023-02-02 — — US disclosed
CN-104837973-A Fragrance materials PROCTER & GAMBLE 2015-08-12 — — CN disclosed
EP-1008579-B1 Cyclopentenebutanol derivatives GIVAUDAN SA (CH) 2004-07-07 — — EP disclosed
EP-1067118-B1 Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances GIVAUDAN SA (CH) 2004-03-31 — — EP disclosed
EP-1008579-A3 Cyclopentenebutanol derivatives Givaudan SA (CH) 2003-01-29 — — EP disclosed
US-6441052-B1 ALKANOL, ALDEHYDE, AND KETONE CYCLOPENTA DERIVATIVES; FRAGRANCES GIVAUDAN SA (CH) 2002-08-27 — — US disclosed
US-20020086901-A1 CYCLOPENTYLALKYL-NITRILES GIVAUDAN SA, A SWITZERLAND CORPORATION 2002-07-04 — — US disclosed
US-6410000-B1 PERFUME GIVAUDAN SA (CH) 2002-06-25 — — US disclosed
US-6399811-B1 ORGANOLEPTIC GIVAUDAN SA (CH) 2002-06-04 — — US disclosed
EP-1067118-A1 Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances Givaudan SA (CH) 2001-01-10 — — EP disclosed
EP-1008579-A2 Cyclopentenebutanol derivatives Givaudan Roure (International) S.A. (CH) 2000-06-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11666881-B2 Process for preparing polysuccinimide derivatives-based microcapsules TFPI, CAPRIN1, PHYKPL ALDH1A1 4360/4885LMNA 3046/4885ALOX15 1846/4885
US-20020086901-A1 CYCLOPENTYLALKYL-NITRILES CCRL2, CBR1, CNR1 ALDH1A1 479/4885LMNA 2186/4885ALOX15 1600/4885
US-12544730-B2 Process for preparing microcapsules ALB, S100A9, S100P ALDH1A1 4213/4885LMNA 1807/4885ALOX15 1654/4885
US-20250345252-A1 COMPOSITE MICROCAPSULES PLIN5, LIPA, PHOSPHO1 ALDH1A1 3819/4885LMNA 539/4885ALOX15 56/4885
US-12383477-B2 Composite microcapsules PLIN5, LIPA, PHOSPHO1 ALDH1A1 3819/4885LMNA 539/4885ALOX15 56/4885
US-12616948-B2 Polyamide microcapsules HDHD5, DDC, USP39 ALDH1A1 4007/4885LMNA 3120/4885ALOX15 3255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.